
ProFound Therapeutics: Innovating impactful disease understanding and therapeutic creation.
ProFound Therapeutics, a pioneering company founded under the Flagship Pioneering umbrella, is dedicated to creating profound impacts on the understanding of biology and disease. The company's core mission is to expand the human proteome beyond traditional boundaries, revealing new possibilities for therapeutic development. ProFound Therapeutics focuses on leveraging advanced scientific insights to innovate and develop novel medicines, aiming to transform the landscape of disease treatment and patient care.
Notable figures affiliated with ProFound Therapeutics include leading scientists and industry experts from Flagship Pioneering. The company has achieved significant milestones in expanding the known human proteome, which has the potential to revolutionize drug discovery and development. By illuminating previously unknown aspects of human biology, ProFound Therapeutics is making a substantial impact on the biotechnology and pharmaceutical industries, paving the way for groundbreaking therapies and improved health outcomes.

Vesalius Therapeutics
vesaliustx.com

Deep Apple Therapeutics
deepappletx.com

Idrx
idrx.com

UTR Therapeutics

Tranquis Therapeutics
tranquis.com

Orbital Therapeutics

Nextrna Therapeutics

Rgenta Therapeutics
rgentatx.com

Sionna Therapeutics
sionnatx.com

Kojin Therapeutics
kojintx.com
Launchpad Therapeutics

NextPoint Therapeutics
nextpointtx.com

Ensem Therapeutics
ensemtx.com

Resilience Therapeutics

Adcentrx Therapeutics
adcentrx.com
Companies similar to ProFound Therapeutics include Vesalius Therapeutics, Deep Apple Therapeutics, Idrx and UTR Therapeutics.
ProFound Therapeutics was founded in 2022.
ProFound Therapeutics' headquarters is located in Cambridge, MA, US.
ProFound Therapeutics' most recent funding round was for $75M (USD) in May 2022.
As of May 27, 2022, ProFound Therapeutics has raised a total of $75M (USD).
ProFound Therapeutics has 35 employees as of Feb 4, 2024.